BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19584892)

  • 1. Reduced ADAMTS13 activity in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Vergouwen MD; Bakhtiari K; van Geloven N; Vermeulen M; Roos YB; Meijers JC
    J Cereb Blood Flow Metab; 2009 Oct; 29(10):1734-41. PubMed ID: 19584892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and significance of vWF, GMP-140 and ADAMTS13 in patients with aneurysmal subarachnoid hemorrhage.
    Li WH; Hui CJ; Ju H
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4350-4356. PubMed ID: 29077161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changes of von willebrand factor/a disintegrin-like and metalloprotease with thrombospondin type I repeats-13 balance in aneurysmal subarachnoid hemorrhage.
    Tang QF; Lu SQ; Zhao YM; Qian JX
    Int J Clin Exp Med; 2015; 8(1):1342-8. PubMed ID: 25785135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage.
    Kumar M; Cao W; McDaniel JK; Pham HP; Raju D; Nawalinski K; Frangos S; Kung D; Zager E; Kasner SE; Levine JM; Zheng XL
    Thromb Haemost; 2017 Apr; 117(4):691-699. PubMed ID: 28102428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.
    Matsukawa M; Kaikita K; Soejima K; Fuchigami S; Nakamura Y; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Shimomura H; Sugiyama S; Fujimoto K; Yoshimura M; Nakagaki T; Ogawa H
    Am J Cardiol; 2007 Sep; 100(5):758-63. PubMed ID: 17719316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction.
    Austin SK; Starke RD; Lawrie AS; Cohen H; Machin SJ; Mackie IJ
    Br J Haematol; 2008 May; 141(4):536-44. PubMed ID: 18341632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome.
    Habe K; Wada H; Matsumoto T; Ohishi K; Ikejiri M; Tsuda K; Kondo M; Kamimoto Y; Ikeda T; Katayama N; Mizutani H
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):622-630. PubMed ID: 26759371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage.
    Wan H; Wang Y; Ai J; Brathwaite S; Ni H; Macdonald RL; Hol EM; Meijers JCM; Vergouwen MDI
    J Thromb Haemost; 2018 Jul; 16(7):1413-1422. PubMed ID: 29729651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13.
    Löwenberg EC; Charunwatthana P; Cohen S; van den Born BJ; Meijers JC; Yunus EB; Hassan MU; Hoque G; Maude RJ; Nuchsongsin F; Levi M; Dondorp AM
    Thromb Haemost; 2010 Jan; 103(1):181-7. PubMed ID: 20062916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
    Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
    Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
    Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased von Willebrand Factor to ADAMTS13 ratio as a predictor of thrombotic complications following a major hepatectomy.
    Kobayashi S; Yokoyama Y; Matsushita T; Kainuma M; Ebata T; Igami T; Sugawara G; Takahashi Y; Nagino M
    Arch Surg; 2012 Oct; 147(10):909-17. PubMed ID: 23117828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation.
    Reiter RA; Varadi K; Turecek PL; Jilma B; Knöbl P
    Thromb Haemost; 2005 Mar; 93(3):554-8. PubMed ID: 15735809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia.
    Vergouwen MD; Vermeulen M; Coert BA; Stroes ES; Roos YB
    J Cereb Blood Flow Metab; 2008 Nov; 28(11):1761-70. PubMed ID: 18628782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic polymorphism of von Willebrand factor (VWF)-cleaving protease, ADAMTS13].
    Kokame K
    Brain Nerve; 2008 Nov; 60(11):1325-32. PubMed ID: 19069166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
    Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
    Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients.
    Bongers TN; de Bruijne EL; Dippel DW; de Jong AJ; Deckers JW; Poldermans D; de Maat MP; Leebeek FW
    Atherosclerosis; 2009 Nov; 207(1):250-4. PubMed ID: 19439298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty.
    Liu L; Ling J; Ma Z; Yuan Q; Pan J; Yang H
    Mol Med Rep; 2015 Apr; 11(4):3015-20. PubMed ID: 25482054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAMTS13 and von Willebrand factor concentrations in patients with diabetes mellitus.
    Skeppholm M; Kallner A; Kalani M; Jörneskog G; Blombäck M; Wallén HN
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):619-26. PubMed ID: 19809308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation.
    Peyvandi F; Siboni SM; Lambertenghi Deliliers D; Lavoretano S; De Fazio N; Moroni B; Lambertenghi Deliliers G; Mannuccio Mannucci P
    Br J Haematol; 2006 Jul; 134(2):187-95. PubMed ID: 16846477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.